CDT Equity Inc. (CDT) vs China SXT Pharmaceuticals, Inc. (SXTC)
A side-by-side comparison of CDT Equity Inc. and China SXT Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDT
CDT Equity Inc.
$0.89HealthcareDelayed quote: Oct 6, 2026, 2:39 PM EDT
SXTC
China SXT Pharmaceuticals, Inc.
$1.35HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
Total return — CDT vs SXTC
growth of $100 · dividends reinvested · last 3yCDT -100.0% (-99.5%/yr)SXTC -100.0% (-96.7%/yr)SXTC compounded faster over this window
Log scale — wide-divergence pair
CDT SXTC
Metrics side by side
SXTC is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.